(Q44037881)

29 November 2017

title

Aprotinin in coronary operation with cardiopulmonary bypass: does "low-dose" aprotinin inhibit the inflammatory response? (English)

1 reference

coronary artery bypass surgery

29 November 2017

0 references

1 reference

5

Thierry P Carrel

1 reference

29 November 2017

Lars Englberger

1

1 reference

29 November 2017

Beat Kipfer

series ordinal

2

1 reference

29 November 2017

Pascal A Berdat

series ordinal

3

1 reference

29 November 2017

Urs E Nydegger

series ordinal

4

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

The Annals of Thoracic Surgery

29 November 2017

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

29 November 2017

volume

73

1 reference

29 November 2017

issue

6

1 reference

29 November 2017

page(s)

1897-1904

1 reference

The inflammatory response and extracorporeal circulation

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2903535-X

Aprotinin and the systemic inflammatory response after cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2903535-X

Aprotinin for primary coronary artery bypass grafting: a multicenter trial of three dose regimens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2903535-X

Low-dose aprotinin for reduction of blood loss after cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2903535-X

A multicenter, double-blind, placebo-controlled trial of aprotinin for reducing blood loss and the requirement for donor-blood transfusion in patients undergoing repeat coronary artery bypass grafting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2903535-X

Effects of minimal-dose aprotinin on coronary artery bypass grafting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2903535-X

Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2903535-X

Pump prime only aprotinin inhibits cardiopulmonary bypass-induced neutrophil CD11b up-regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2903535-X

Aprotinin enhances the endogenous release of interleukin-10 after cardiac operations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2903535-X

Reducing the post-pump syndrome by using heparin-coated circuits, steroids, or aprotinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2903535-X

"Low-dose" aprotinin modifies hemostasis but not proinflammatory cytokine release.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2903535-X

Complement activation during major surgery: the effect of extracorporeal circuits and high-dose aprotinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2903535-X

Influence of low-dose aprotinin on the inflammatory reaction due to cardiopulmonary bypass in children

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2903535-X

Economic evaluation of high-dose and low-dose aprotinin therapy during cardiopulmonary bypass

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2903535-X

Fibrin formation and degradation in patients with arteriosclerotic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2903535-X

Influence of high- and low-dose aprotinin on activation of hemostasis in open heart operations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2903535-X

Impact of left ventricular dysfunction on cytokines, hemodynamics, and outcome in bypass grafting.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2903535-X

Activation of coagulation and fibrinolysis during cardiothoracic operations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2903535-X

Aprotinin. A review of its pharmacology and therapeutic efficacy in reducing blood loss associated with cardiac surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2903535-X

An anti-inflammatory property of aprotinin detected at the level of leukocyte extravasation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0003-4975%2802%2903535-X

10.1016/S0003-4975(02)03535-X

7 January 2021

Identifiers

DOI

1 reference

29 November 2017

1 reference